What is the official ID of this bill?

The official print number for this legislation is HR 4881.

When did the legislative process begin?

The process officially started on 2023-07-25.

Where can I read the full text of this legislation?

The full official text is available at: https://www.congress.gov/118/bills/hr4881/BILLS-118hr4881ih.htm

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

Who is the primary sponsor?

The primary sponsor is Rep. Malliotakis, Nicole [R-NY-11].

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Analysis and Potential Impact of HR 4881

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

Limiting Drug Costs in Medicare Program

Q: What are the main provisions?

Key points include: Beginning in 2027, monthly drug costs under Medicare Part D will be capped at the average net price or lower cash price. The change is designed to lower medication expenses for low-income individuals enrolled in Medicare. A government report is planned to assess compliance and enforcement of the new provisions.

This bill aims to limit the amounts individuals in the Medicare Part D program have to pay for their medications. Starting in 2027, monthly drug costs will not exceed the average net price of the drug or the lower cash price at the pharmacy. This is intended to reduce financial burdens for patients.

Key points

Beginning in 2027, monthly drug costs under Medicare Part D will be capped at the average net price or lower cash price.

The change is designed to lower medication expenses for low-income individuals enrolled in Medicare.

A government report is planned to assess compliance and enforcement of the new provisions.

article Official text account_balance Process page notifications_active Track this Bill

gavel

Status:

Expired

Record your position for audit.

Why does your vote on bills matter?

It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.

Additional Information

To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program.

Print number: HR 4881

Sponsor: Rep. Malliotakis, Nicole [R-NY-11]

Process start date: 2023-07-25

System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.

Summarized by: gemini-2.5-flash-preview-05-20

Source data: api.congress.gov

AI work logs for this document launch

Limiting Drug Costs in Medicare Program

Key Questions about Limiting Drug Costs in Medicare Program